AM-1248

AM-1248
Legal status
Legal status	CA: Schedule II; DE: NpSG (Industrial and scientific use only); NZ: Temporary Class; UK: Class B;
Identifiers
	IUPAC name 1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole;
CAS Number	335160-66-2 ;
PubChem CID	10293794;
ChemSpider	8469262 ;
UNII	5EX9HEF4HK;
Chemical and physical data
Formula	C26H34N2O
Molar mass	390.571 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN1CCCCC1Cn(c6)c2ccccc2c6C(=O)C5(C3)CC(CC3C4)CC4C5;
	InChI InChI=1S/C26H34N2O/c1-27-9-5-4-6-21(27)16-28-17-23(22-7-2-3-8-24(22)28)25(29)26-13-18-10-19(14-26)12-20(11-18)15-26/h2-3,7-8,17-21H,4-6,9-16H2,1H3 ; Key:JRECAXBHMULNJQ-UHFFFAOYSA-N ;
	(what is this?) (verify)

AM-1248 is a drug that acts as a moderately potent agonist for both the cannabinoid receptors CB₁ and CB₂, but with some dispute between sources over its exact potency and selectivity. Replacing the 3-(1-naphthoyl) group found in many indole derived cannabinoid ligands, with an adamant oyl group, generally confers significant CB₂ selectivity, but reasonable CB₁ affinity and selectivity is retained when an N-methylpiperidin-2-ylmethyl substitution is used at the indole 1-position. The related compound 1-pentyl-3-(1-adamantoyl)indole was identified as having been sold as a cannabinoid designer drug in Hungary in 2011, along with another synthetic cannabinoid AM-679.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.